Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers

ClinicalTrials.gov ID: NCT00318214

Public ClinicalTrials.gov record NCT00318214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a clinical research study of an experimental topical drug for the treatment of chronic, neuropathic, diabetic foot ulcers. The purpose of the study is to determine the safety of the experimental drug when applied to large, diabetic foot ulcers. The study will also determine if the experimental drug can safely promote healing of diabetic foot ulcers better than standard treatments currently available to doctors. Patients participating in the study may receive an active drug (MRE0094) or inactive drug (placebo). What treatment a patient will receive is determined by chance (like drawing a number from a hat). All patients will receive additional care for diabetic foot ulcers during the study. Participation in the study can be up to 4½ months.

Study identification

NCT ID
NCT00318214
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
16 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2006 (Type not available)
Primary completion
Feb 2008 (Actual)
Completion
Feb 2008 (Actual)
Last update posted
Jun 1, 2012

2006 – 2008

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Associated Foot & Ankle Specialists, LLC Phoenix Arizona 85015 —
Southern Arizona VA Health Care System Tucson Arizona 85723 —
Roy O. Kroeker, DPM Fresno California 93710 —
Innovative Medical Technologies Los Angeles California 90063 —
Diabetic Foot & Wound Center Denver Colorado 80220 —
North American Center for Limb Preservation New Haven Connecticut 06515 —
Karr Foot & Leg Centers Lakeland Florida 33813 —
University of Miami Miami Florida 33136 —
Ankle and Foot Specialist of Atlanta Lithonia Georgia 30058 —
Foot Healthcare Associates Livonia Michigan 48152 —
Northern Michigan Hospital Petoskey Michigan 49770 —
North Shore Podiatry Group Port Jefferson Station New York 11776 —
Calvary Hospital The Bronx New York 10461 —
UNC Wound Care Clinic Durham North Carolina 27713 —
Eastern Carolina Foot & Ankle Specialists Greenville North Carolina 27834 —
Lehigh Valley Podiatry Associates Allentown Pennsylvania 18104 —
Limb Salvage Center Dallas Texas 75231 —
Southwest Regional Wound Care Lubbock Texas 79410 —
St. Luke's Medical Center Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00318214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2012 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00318214 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →